Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer of Bone”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02063022
What this trial is testing

Efficacy of Dose Intensification in Patients With Non-metastatic Ewing Sarcoma

Who this might be right for
Ewing's Sarcoma
Italian Sarcoma Group 278
Early research (Phase 1)Study completedNCT00642031
What this trial is testing

Triciribine Phosphate Monohydrate (TCN-PM, VD-0002) in Adult Patients With Advanced Hematologic Malignancies

Who this might be right for
Hematologic MalignanciesLeukemia
Prescient Therapeutics, Ltd. 20
Early research (Phase 1)Study completedNCT00380653
What this trial is testing

Safety and Pharmacology Study of Sapacitabine to Treat Advanced Leukemias or Myelodysplastic Syndromes

Who this might be right for
LeukemiasMyelodysplastic Syndromes
Cyclacel Pharmaceuticals, Inc. 47
Testing effectiveness (Phase 2)Active Not RecruitingNCT07096583
What this trial is testing

An Exploratory Study on NK Cell-assisted Prevention of Bone Marrow Suppression During Chemotherapy for Ovarian Cancer

Who this might be right for
Ovary Cancer
Anhui Provincial Cancer Hospital 20
Not applicableLooking for participantsNCT06146231
What this trial is testing

Motiva Flora® Aesthetic Breast Recon® Clinical Study

Who this might be right for
MammaplastyBreast CancerPoland Syndrome
Establishment Labs 66
Not applicableUnknownNCT05730972
What this trial is testing

TEAS for the Treatment of Pain in Bone Metastases of Lung Cancer

Who this might be right for
Cancer PainNon Small Cell Lung CancerBone Metastases+1 more
The Third Affiliated hospital of Zhejiang Chinese Medical University 188
Large-scale testing (Phase 3)Ended earlyNCT04308395
What this trial is testing

Extension Study of Patidegib Topical Gel, 2% in Subjects With Gorlin Syndrome (Basal Cell Nevus Syndrome)

Who this might be right for
Basal Cell Nevus Syndrome
Sol-Gel Technologies, Ltd. 108
Large-scale testing (Phase 3)Ended earlyNCT00236002
What this trial is testing

Cancer and Osteoporosis Research With Alendronate and Lupron (C.O.R.A.L )

Who this might be right for
Osteoporosis
Canadian Urology Research Consortium 182
Not applicableStudy completedNCT00935870
What this trial is testing

Bioactive Glass as Bone Graft Substitute in Operative Treatment of Bone - a 10 Years Follow-up Study

Who this might be right for
Depressed Lateral Condyle FractureBenign Bone Tumour CavitySpinal Fusion
Vivoxid Ltd 63
Testing effectiveness (Phase 2)Ended earlyNCT03176277
What this trial is testing

ONO-7475 in Patients With Acute Leukemias

Who this might be right for
Acute LeukemiaMyelodysplastic Syndromes
Ono Pharmaceutical Co., Ltd. 42
Not applicableStudy completedNCT00038675
What this trial is testing

Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate

Who this might be right for
Chronic Myelomonocytic LeukemiaChronic Myeloid LeukemiaPolycythemia Vera+2 more
M.D. Anderson Cancer Center 125
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07698080
What this trial is testing

Dexamethasone, Intravenous Injection of Human Immunoglobulin, and Increased Infusion of Mononuclear Cells to Reduce Donor Specific Antibodies in Haploidentical Hematopoietic Stem Cell Transplantation

Who this might be right for
LeukemiaLymphomaThalassemia+2 more
Hematology department of the 920th hospital 60
Testing effectiveness (Phase 2)Study completedNCT00254423
What this trial is testing

Dasatinib in Treating Patients With Early Chronic Phase Chronic Myelogenous Leukemia

Who this might be right for
Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositivePhiladelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia
M.D. Anderson Cancer Center 150
Testing effectiveness (Phase 2)Study completedNCT01492673
What this trial is testing

Cyclophosphamide, Topotecan, and Bevacizumab (CTB) in Patients With Relapsed/Refractory Ewing's Sarcoma and Neuroblastoma

Who this might be right for
NeuroblastomaSarcoma
Memorial Sloan Kettering Cancer Center 9
Testing effectiveness (Phase 2)Looking for participantsNCT06699472
What this trial is testing

A Prospective, Randomized, Controlled Clinical Study on the Prevention of Chemotherapy Related Myelosuppression in Patients with Ewing's Sarcoma Using Trilaciclib

Who this might be right for
Ewing SarcomaMyelosuppression
Fudan University 22
Not applicableStudy completedNCT00919139
What this trial is testing

S0309, Repository: Blood/Bone Marrow From Pts. With Myeloma, WM, Amyloidosis, or MGUS.

Who this might be right for
Multiple MyelomaSmoldering MyelomaWaldenstrom's Macroglobulinemia+2 more
SWOG Cancer Research Network 190
Testing effectiveness (Phase 2)Active Not RecruitingNCT04517851
What this trial is testing

Elotuzumab for the Treatment of JAK2-Mutated Myelofibrosis

Who this might be right for
Myelofibrosis Transformation in Essential ThrombocythemiaPolycythemia Vera, Post-Polycythemic Myelofibrosis PhasePrimary Myelofibrosis
M.D. Anderson Cancer Center 15
Large-scale testing (Phase 3)Active Not RecruitingNCT05115331
What this trial is testing

Palliative UNConventional Hypofractionation Trial for Metastatic Bone Disease

Who this might be right for
Metastatic Bone Tumor
University of Cincinnati 168
Not applicableStudy completedNCT00386373
What this trial is testing

Use and Tolerability of Imatinib Mesylate (Gleevec) in Leukemia Patients

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 10
Early research (Phase 1)Ended earlyNCT04250051
What this trial is testing

Ivosidenib and Combination Chemotherapy for the Treatment of IDH1 Mutant Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Recurrent Acute Myeloid LeukemiaRecurrent Myelodysplastic SyndromeRecurrent Myeloproliferative Neoplasm+5 more
Northwestern University 2
Next Page